PASTORELLI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 5.695
NA - Nord America 3.893
AS - Asia 2.519
SA - Sud America 144
OC - Oceania 41
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.319
Nazione #
US - Stati Uniti d'America 3.813
GB - Regno Unito 2.650
CN - Cina 1.099
IT - Italia 816
SG - Singapore 594
SE - Svezia 551
DE - Germania 453
RU - Federazione Russa 262
IN - India 198
IE - Irlanda 176
FR - Francia 166
ID - Indonesia 114
TR - Turchia 101
JP - Giappone 99
KR - Corea 98
BR - Brasile 96
GR - Grecia 94
UA - Ucraina 93
HK - Hong Kong 90
FI - Finlandia 87
DK - Danimarca 75
CA - Canada 71
ES - Italia 67
NL - Olanda 54
AU - Australia 33
PL - Polonia 28
BE - Belgio 22
NO - Norvegia 21
VN - Vietnam 21
CH - Svizzera 19
EU - Europa 19
CO - Colombia 18
AT - Austria 15
TW - Taiwan 15
UZ - Uzbekistan 14
CZ - Repubblica Ceca 13
IR - Iran 12
CL - Cile 11
RO - Romania 11
IL - Israele 9
PH - Filippine 9
PT - Portogallo 9
MY - Malesia 8
NZ - Nuova Zelanda 8
EG - Egitto 6
PE - Perù 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
LK - Sri Lanka 5
MX - Messico 5
BD - Bangladesh 4
EC - Ecuador 4
VE - Venezuela 4
AR - Argentina 3
NG - Nigeria 3
PK - Pakistan 3
SC - Seychelles 3
ZA - Sudafrica 3
AP - ???statistics.table.value.countryCode.AP??? 2
LB - Libano 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
ME - Montenegro 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 12.336
Città #
Southend 2.499
Chandler 465
Singapore 444
Fairfield 330
Seattle 289
Milan 255
Wilmington 241
Ashburn 216
Princeton 191
Beijing 183
Dublin 176
Woodbridge 173
Houston 136
Cambridge 121
Ann Arbor 120
Dearborn 108
Jakarta 102
Hanover 85
Nanjing 81
Frankfurt am Main 80
Redwood City 76
Des Moines 72
Bengaluru 64
Shanghai 62
Santa Clara 58
Hong Kong 55
Guangzhou 51
Andover 46
Phoenix 46
Redmond 46
Jacksonville 43
Boardman 42
Berlin 39
Mountain View 35
New York 34
Helsinki 33
Chengdu 32
Shenyang 31
Tokyo 30
London 28
Turin 28
Jinan 26
Rome 26
Nuremberg 25
Toronto 24
Wuhan 23
Chicago 20
Ottawa 20
Warsaw 20
Seoul 19
Hangzhou 18
Madrid 18
Nanchang 18
San Diego 18
Changsha 17
Hefei 17
Serra 17
Saint Petersburg 16
Athens 14
Bitonto 14
Fuzhou 14
Istanbul 14
Munich 14
Bogotá 13
Como 13
Costa Mesa 13
Los Angeles 13
Ningbo 13
Brussels 12
Central District 12
Hebei 12
Hyderabad 12
San Francisco 12
São Paulo 12
Upper Marlboro 12
Zhengzhou 12
Fremont 11
North Bergen 11
Paris 11
Tianjin 11
Jiaxing 10
Lanzhou 10
Silver Spring 10
Bühl 9
Sakarya 9
Somerville 9
Xian 9
Amsterdam 8
Barcelona 8
Brno 8
Central 8
Chongqing 8
Eitensheim 8
Erlangen 8
Harbin 8
Santiago 8
Shenzhen 8
Vienna 8
Auburn Hills 7
Cagliari 7
Totale 8.031
Nome #
Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study 591
Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea : a prospective, multicenter study 402
Outcomes of COVID-19 in 79 patients with IBD in Italy : an IG-IBD study 316
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion 305
Major duodenal papilla prolapse in Cronkhite-Canada syndrome 224
Small-bowel capsule endoscopy with panoramic view : results of the first multicenter, observational study (with videos) 219
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 209
Extensive small-bowel Crohn's disease detected by the newly introduced 360° panoramic viewing capsule endoscopy system 207
Editorial : the increasing burden of microscopic colitis 201
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 189
Bowel Sonoelastography in Patients with Crohn's Disease : a Systematic Review 189
Over-the-scope clip-assisted endoscopic full-thickness resection after incomplete resection of rectal adenocarcinoma 186
Biomarkers and Microscopic Colitis : An Unmet Need in Clinical Practice 185
Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function 180
Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism 177
IL-33 activates tumor stroma to promote intestinal polyposis 176
The role of IL-33 in gut mucosal inflammation 175
Interleukin-33 selectively expands interleukin-17 producing CD 11b+ cell population in an experimental model of spontaneus intestinal inflammation 171
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MmxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report a pilot study 169
Outcome of transfusion-associated chronic hepatitis C depends on patient age at infection 166
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 166
Adrenal incidentalomas (AI) in patients with hereditary hemochromatosis (HH) 163
Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation : Lessons Learned from Animal Models and Human Genetics 161
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 159
Aberrant expression of IFI16 in the intestinal epithelia from inflammatory bowel disease is induced by pro-inflammatory cytokines 159
Associations between genetic polymorphism in IL-33, IL1R1 and risk for inflammatory bowel disease 158
Prevalence of microscopic colitis in subjects undergoing colonoscopy for non-bloody diarrhea : a prospective epidemiological study 156
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? 151
A consumer's guide for probiotics : 10 golden rules for a correct use 143
Do antibodies have a role in IBD pathogenesis? 135
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis 134
A rare case of angina bullosa hemorrhagica of the esophagus 133
Hepcidin is a pivotal mediator of infliximab-induced improvement of iron metabolism in inflammatory bowel diseases 131
Endoscopic full-thickness resection for T1 early rectal cancer : a case series and video report 127
Microscopic colitis and colorectal neoplastic lesions in patients with chronic non-bloody diarrhea : a prospective multicenter study 127
Inflammatory bowel disease (IBD) : biomarkers identification by proteomic approach 126
Emerging drugs for the treatment of ulcerative colitis 125
Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea : a prospective, multicenter study 124
Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres 124
Severe azathioprine-induced liver injury 22 months after initiation of treatment 122
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 122
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives 121
In-vivo axial-strain sonoelastography helps distinguish acutely-inflamed from fibrotic terminal ileum strictures in patients with Crohn's disease : preliminary results 120
SAMP1/YitFc mouse strain : a spontaneous model of Crohn's disease-like ileitis 119
IL-33 triggers early eosinophil-dependent events leading to metaplasia in a chronic model of gastritis-prone mice 119
Prevalence and clinical significance of antibodies anti-IFI 16 in inflammatory bowel diseases 118
Infliximab-Mediated modulation of Hepcidin improves iron metabolism in Inflammatory Bowel Disease 116
Proinflammatory Interleukin-33 Induces Dichotomic Effects on Cell Proliferation in Normal Gastric Epithelium and Gastric Cancer 114
Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis 113
Corrigendum: Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice (Frontiers in Medicine, (2017), 4, 10.3389/fmed.2017.00054) 113
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 113
Spontaneous, immune-mediated gastric inflammation in SAMP1/YitFc mice, a model of Crohn's-like gastritis 109
MMX® technology and its applications in gastrointestinal diseases 109
Dichotomous effects of interleukin-33 on gastric and intestinal epithelial cell proliferation 108
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study 108
PC.1.3: IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy : potential role in inflammatory-associated gut fibrosis 106
Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy 105
Ex vivo experimental study on the Thulium laser system : new horizons for interventional endoscopy (with videos) 103
Distinct Anti-IFI16 and Anti-GP2 antibodies in inflammatory bowel disease and their variation with infliximab therapy 101
Usefulness of panoramic 344°-viewing in Crohn's disease capsule endoscopy : a proof of concept pilot study with the novel PillCam™ Crohn's system 100
Advances in endoscopic imaging in ulcerative colitis 99
Proteomic insights on the metabolism in inflammatory bowel disease 98
Over-the-scope clipping in recurrent colonic diverticular bleeding 96
Thulium laser in interventional endoscopy : animal and human studies 95
High prevalence of antibodies anti-interferon-inducible IFI16 protein in inflammatory bowel diseases 94
Idea for in vivo differentiation of ulcerative colitis and Crohn's disease with confocal laser endomicroscopy 94
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis : a real-life experience 94
IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy : potential role in inflammatory-associated gut fibrosis 93
Pro-inflammatory cytokines Induce aberrant interferon-inducible IFI16 protein expression in inflammatory bowel disease epithelium 91
Microscopic colitis and colorectal neoplastic lesions in patients with chronic non-bloody diarrhea : a prospective, Multicenter Study 90
Novel cytokine signaling pathways in inflammatory bowel disease : insight into the dichotomous functions of IL-33 during chronic intestinal inflammation 86
Efficacy and tolerability of high and low-volume bowel preparation compared : A real-life single-blinded large-population study 84
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 81
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 81
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy : an IG-IBD study 80
IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis 80
Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis 79
Use of an over-the-scope clip for endoscopic sealing of anastomotic dehiscence after anterior resection for rectal cancer 76
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 73
In vitro effect of Interleukin-33 on gastric adenocarcinoma cell line (AGS) and intestinal epithelial cancer cell line (Caco-2) 72
Anti-TNF Therapy Improves Stored Body Iron Serum Markers in Inflammatory Bowel Disease Patients 71
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system 70
Mo1779 interleukin-33 induces distinct gastric epithelial alterations and plays an important role in the pathogenesis of murine gastritis 69
Multidimensional Prognostic Index Predicts Clinical Outcome and Mortality in Hospitalised Older Patients with Diverticular Disease 65
Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD : A Domino Effect 63
Microscopic Colitis : What Do We Know About Pathogenesis? 59
Interleukin-37 : a Peacekeeper at the Intestinal Borders 59
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 58
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 56
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 55
Response to "italian ibd patients coping with covid-19 emergency : The mitigating role of psychological readiness to engage in self-care 53
Staging esophageal cancer: low EUS accuracy in t2n0 patients 52
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 50
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 50
Low prevalence of colorectal neoplasia in microscopic colitis : A large prospective multi-center study 49
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study 47
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 47
Editorial: The Dark Side of Microscopic Colitis 47
Constrained multiple instance learning for ulcerative colitis prediction using histological images 46
AN update on probiotic therapy for chronic inflammatory bowel diseases in adults 46
Totale 12.546
Categoria #
all - tutte 45.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020848 0 0 0 0 0 0 135 117 239 170 116 71
2020/20212.121 189 159 143 134 192 140 109 190 233 170 286 176
2021/20222.038 181 165 147 196 166 141 144 133 245 188 63 269
2022/20231.782 190 171 158 186 175 304 50 96 187 67 149 49
2023/20241.407 68 99 90 72 334 93 90 97 37 85 155 187
2024/20251.387 131 324 73 305 278 225 51 0 0 0 0 0
Totale 13.015